METTL14 Acts as a Potential Regulator of Tumor Immune and Progression in Clear Cell Renal Cell Carcinoma.

Frontiers in Genetics
Tianbo XuXiaoping Zhang

Abstract

Clear cell renal cell carcinoma (ccRCC) is characterized by its insensitivity to chemoradiotherapy and lacks effective diagnostic and prognostic biomarkers. In this study, we focused on the role of m6A RNA methylation regulators for tumor immunity. Based on the expression of 20 m6A regulators, consensus clustering was performed to divide patients into cluster1/cluster2 and showed that there was a survival difference between the two clusters. Through cox regression analysis, five hub m6A regulators were screened to construct a risk model. Further analysis showed that the risk score was an independent prognostic factor. GSEA, GSVA, and KEGG analysis revealed that immune cell pathways played a critical role between the high risk group and low risk group. Combined with CIBERSORT and survival analysis, five hub tumor-infiltrating immune cells (TIICs) were identified for further study. Meanwhile, correlation analysis indicated that IGF2BP2 was positively associated with activated memory CD4 T cell and METTL14 was negatively correlated to the regulatory T cell. Therefore, IGF2BP2 and METTL14 were regarded as key genes. Further study verified that only METTL14 possessed good diagnostic and prognostic value. Then, GSEA exhibited that ME...Continue Reading

References

Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Nov 23, 2007·Nature·Lauren W CollisonDario A A Vignali
Aug 20, 2008·Nature Immunology·Shannon K BromleyAndrew D Luster
Apr 30, 2010·Bioinformatics·Matthew D Wilkerson, D Neil Hayes
Mar 30, 2012·Omics : a Journal of Integrative Biology·Guangchuang YuQing-Yu He
Jan 18, 2013·BMC Bioinformatics·Sonja HänzelmannJustin Guinney
Apr 4, 2013·Science Signaling·Jianjiong GaoNikolaus Schultz
Oct 12, 2013·Nature Communications·Kosuke YoshiharaRoel G W Verhaak
Apr 10, 2014·Nature Reviews. Molecular Cell Biology·Kate D Meyer, Samie R Jaffrey
Dec 18, 2014·Genome Biology·Michael I LoveSimon Anders
Jan 22, 2015·Nucleic Acids Research·Matthew E RitchieGordon K Smyth
Jan 27, 2015·European Urology·Borje LjungbergAxel Bex
Sep 1, 2015·Lancet·Umberto Capitanio, Francesco Montorsi
Feb 4, 2016·Nature Structural & Molecular Biology·Nian Liu, Tao Pan
Oct 25, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jin-Zhao MaShu-Han Sun
Jan 6, 2017·Cancer Immunology Research·Dmitry I Gabrilovich
Jan 25, 2017·Nature Reviews. Clinical Oncology·Alberto MantovaniPaola Allavena
Oct 1, 2016·Asian Journal of Urology·Jun GongSumanta K Pal
Apr 5, 2018·Immunology and Cell Biology·Janine GototChristian Kurts
Mar 22, 2019·Cancer Research·Qing LanTao Liu
Apr 28, 2019·Proceedings of the National Academy of Sciences of the United States of America·Takahiro KamadaHiroyoshi Nishikawa
May 19, 2019·Cancer Science·Yoshihiro Ohue, Hiroyoshi Nishikawa
May 31, 2019·Molecular Cancer·Xiao-Yu ChenJin-Shui Zhu
Jan 9, 2020·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Apr 9, 2020·International Journal of Molecular Sciences·Antoine DeleuzeSolène-Florence Kammerer-Jacquet
May 8, 2020·Acta Neuropathologica Communications·Albert Z HuangPoul H Sorensen

❮ Previous
Next ❯

Software Mentioned

R
ggplot2
GSEA
CIBERSORT
LASSO
cBioPortal
cytoscape
glmnet
corrplot
ESTIMATE

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.